Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01328873 · ClinicalTrials.gov registry record · NA
FOB in HSCT and Leukemia Patients With Acute Respiratory Symptoms and Pulmonary Infiltrates
A NA study, sponsored by Northside Hospital.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT01328873 is a NA study that has completed, run by Northside Hospital. The registered enrollment target is 49 participants.
The verdict
NCT01328873, a NA study, has completed, sponsored by Northside Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
Pulmonary infiltrates frequently complicate the care of hematopoietic stem cell transplant (HSCT) and leukemia patients. Bronchoalveolar lavage (BAL) is frequently used to evaluate new pulmonary infiltrates in this population, however utility is limited by a historically low diagnostic yield for infection. In an effort to improve diagnostic yields, this study will complete a Fiberoptic Bronchoscopy (FOB) within 8 hours of radiographic documentation of pulmonary infiltrates, prior to initiating new antibiotic therapy. To further improve detection of microbiological pathogens, the study will utilize PCR testing with rapid turnaround time to detect atypical pneumonia (M pneumoniae, C. Pneumonia, Legionella species, and respiratory viruses) and aspergillosis.
Interventions
- OTHER Microbiological analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2011-03 |
| Est. Completion | 2017-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01328873
The ClinicalTrials.gov registry entry for NCT01328873 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northside Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Microbiological analysis is the first listed.
NCT01328873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01328873 about?
NCT01328873 is a clinical study titled "FOB in HSCT and Leukemia Patients With Acute Respiratory Symptoms and Pulmonary Infiltrates". Pulmonary infiltrates frequently complicate the care of hematopoietic stem cell transplant (HSCT) and leukemia patients. Bronchoalveolar lavage (BAL) is frequently used to evaluate new pulmonary infiltrates in this population, however utility is limited by a historically low diagnostic yield for inf...
What is the current status of trial NCT01328873?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2011-03. Estimated completion is 2017-04.
What interventions are being tested in trial NCT01328873?
The interventions under investigation include: Microbiological analysis (OTHER).
Who is sponsoring clinical trial NCT01328873?
This trial is sponsored by Northside Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.